Tag: NVAF
Low bleeding and cardiovascular events in elderly NVAF patients using edoxaban,...
Daiichi Sankyo has announced one-year follow-up results from an analysis of 12,574 European non-valvular atrial fibrillation (NVAF) patients, mostly elderly, treated with edoxaban (Lixiana)....